MeSH tree: D06
Alcohol use appears to trigger specific biological changes in the human body that are linked to the development of chronic disease. These biological changes are already apparent in young adults with a short history of alcohol ...
Sep 7, 2026
0
8
Many prostate cancers depend on androgen hormones, including testosterone, to grow. That is why treatments for advanced disease often try to reduce testosterone production or block its effects. Now, scientists have identified ...
Sep 7, 2026
0
27
Testosterone is having a moment. On social media, it's being lauded for everything from building muscle to gaining wealth and sexual dominance.
Sep 4, 2026
0
8
We've all been there. You spend an hour at the gym, and before you even reach the locker room, you start thinking about your favorite takeout meal—after all, you've earned it!
Sep 4, 2026
0
14
The influence of the hormone progesterone on mood is well known. Now, researchers from the University of Barcelona have shown how higher levels of progesterone during the menstrual cycle are linked to less distinct patterns ...
Sep 2, 2026
0
24
University of Missouri researchers are studying high blood pressure, one of the world's deadliest health threats. Recently, they identified a protein that contributes to arterial stiffening and inflammation, opening the door ...
Sep 2, 2026
0
273
A study published in Nature has shown that the GLP-1 drug semaglutide extended the lifespan of older, healthy mice by tempering the detrimental effects of aging. Researchers at the University of California, Berkeley, directly ...
Sep 2, 2026
0
28
The number of people living with type 1 diabetes worldwide is projected to jump nearly 30% over the next two decades, from 9.4 million today to 12.1 million by 2049.
Sep 1, 2026
0
6
Vanderbilt researchers have discovered why the adage, "breakfast is the most important meal of the day," holds weight—especially for the 1 in 9 adults worldwide living with diabetes. Glucose (the simplest form of sugar) is ...
Sep 1, 2026
0
163
An updated systematic review evaluating the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and coagonists among adults with overweight or obesity without diabetes found that, among currently ...
Sep 1, 2026
0
17
